Head and Neck Squamous Cell Carcinoma (HNSCC) Not Yet Recruiting Phase 4 Trials for DB00293 (Raltitrexed)

Also known as: Head and Neck Squamous Cell Carcinoma

IndicationStatusPhase
DBCOND0043665 (Head and Neck Squamous Cell Carcinoma (HNSCC))Not Yet Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03196843Radiotherapy Combine With Raltitrexed Versus Radiotherapy Alone in Older Patients With HNSCC.Treatment